News Briefing channel feed – Endpoints News

News Briefing channel feed

J&J heads to FDA for Vyvgart competitor; Tokyo conglomerate launches venture fund

10 months ago

SpringWorks gets priority review; Botox competitor data; Hyundai's Covid treatment; Arcus takes a loan

10 months ago

Redalpine closes $200M fund; A base editing pact in China; Merck starts another Phase 3 for Imago drug

10 months ago

Mpox vaccine collab; $11M oncology seed; Gates backs RSV vaccine; Kyowa Kirin slims portfolio

10 months ago

Novo's innovation hub expands to Bay Area; SIGA's new Tpoxx order

10 months ago

Vandria raises another $10M; Nykode ends Phase 2 trial in cervical cancer

10 months ago

Kymera seeks to raise $225M; Adcendo, Multitude's new ADC deal

10 months ago

Avidity’s upsized $345M offering; Janus Henderson’s new $150M biotech fund

10 months ago

AN2’s poison pill; Pfizer shares promising mid-stage data for flu shot

10 months ago

Lyra pauses work on sinusitis drug; Pathos AI licenses a new asset

10 months ago

Another offering for Avidity; Galera shuts down

11 months ago

Kyverna shares safety data for CAR-T; Evotec gets $75M milestone

11 months ago

Tenax raises $100M; Sanofi buys into MeiraGTx

11 months ago

A CAR-T deal in China; Zevra’s $60M offering

11 months ago

Roivant to 'unveil' pipeline addition next month; Bavarian Nordic gets $156M from US

11 months ago

Stoke Therapeutics’ partial hold lifted; Recursion gets $30M from Roche

11 months ago

BioCryst culls Factor D inhibitor; Elevation Oncology’s stock plummets

11 months ago

Layoffs at Sumitomo; Galderma and L’Oréal strike a deal

11 months ago

Blueprint ups Ayvakit guidance; Aurinia to advance autoimmune disease asset

11 months ago

Ideaya and Biocytogen ink $400M+ deal; Daiichi spends more on superstar ADCs

11 months ago

Day One's $175M PIPE; Pinetree raises $17M in Series A

11 months ago

Collegium pays $525M to buy ADHD company; FDA delays Syndax decision

11 months ago

ProMIS announces PIPE up to $122M; Confo raises €60M in Series B

11 months ago

Galderma deprioritizes study for IL-31 drug; UCB stops work in rare encephalitis

11 months ago

First page Previous page 6 7 8910 11 12 Next page Last page